- Home
- A-Z Publications
- Current Medicinal Chemistry - Cardiovascular & Hematological Agents
- Previous Issues
- Volume 3, Issue 1, 2005
Current Medicinal Chemistry - Cardiovascular & Hematological Agents - Volume 3, Issue 1, 2005

Volume 3, Issue 1, 2005
-
-
Discovery and Pre-clinical Development of Antithrombotics from Hematophagous Invertebrates
Authors: Michel Ledizet, Lisa M. Harrison, Raymond A. Koski and Michael CappelloBloodfeeding (hematophagous) parasites have evolved effective means of inhibiting mammalian thrombosis, thereby facilitating the acquisition and digestion of a bloodmeal. To date, specific inhibitors of coagulation and platelet function have been identified from numerous invertebrate species, representing an impressive array of convergent functional strategies. These parasite antithrombotics, in addition to playing a critical rol Read More
-
-
-
Vasoprotective Actions of the Atrial Natriuretic Peptide
Authors: Alexandra K. Kiemer, Robert Furst and Angelika M. VollmarThe Natriuretic Peptide (NP) family, especially its best-characterized member Atrial Natriuretic Peptide (ANP), plays an important role in the regulation of blood pressure homeostasis and salt and water balance. Besides their action in cardiovascular physiology, NPs have been described as anti-inflammatory regulators of macrophage function: they have been reported to inhibit the induction of inflammatory mediators, su Read More
-
-
-
Targeting the Renin-angiotensin System: What's New?
By B. J. LeckieThe renin-angiotensin system is a key target for drugs combating cardiovascular disease. Angiotensinconverting enzyme (ACE) inhibitors and angiotensin receptor type-1 (AT1 receptor) blockers are well known. However, angiotensin peptides can be generated through a number of pathways besides the classic system. This review outlines some of these pathways, their relation to the classic system and the likely effe Read More
-
-
-
The Plasma and Tissue Kininogen-kallikrein-kinin System: Role in the Cardiovascular System
Authors: S. Marcondes and E. AntunesBradykinin and Lys-bradykinin are potent peptide mediators implicated in several physiopathological effects in mammals. They act through activation of G-protein-coupled constitutive B2 or inducible kinin B1 receptors linked to signaling pathways involving increased intracellular Ca++ concentrations and / or release of mediators including arachidonic acid metabolites, NO and EDHF. In the cardiovascular system, the kall Read More
-
-
-
Smoking, Estradiol Metabolism and Hormone Replacement Therapy
Authors: Alfred O. Mueck and Harald SeegerMany women receiving hormone replacement therapy (HRT) smoke; in the Women's Health Initiative (WHI), one of the largest interventional studies on HRT to date and which recently had to be discontinued, 50% of the 8,500 women on HRT had smoked before or continued to smoke during the study. Remarkably, there is little knowledge about the impact smoking has on the efficacy and side effects of HRT. However, it has been Read More
-
-
-
Influence of Chronic Kidney Disease Development and Renin-angiotensin System Inhibition on Cardiovascular Prognosis
Authors: J. Segura, C. Campo and L. M. RuilopeRecently published guidelines recognize the relevance of the development of chronic kidney disease in the stratification of risk of the hypertensive patient. Adequate assessment of renal function, including estimation of glomerular filtration rate, is mandatory in order to ensure an adequate evaluation of global cardiovascular risk in the hypertensive patient. The presence of subtle elevations of serum creatinine concentration Read More
-
-
-
Left Ventricular Hypertrophy and Angiotensin II Receptor Blocking Agents
Authors: K. Yasunari, K. Maeda, M. Nakamura, T. Watanabe, J. Yoshikawa and K HirohashiAngiotensin II plays a significant role in cell growth and proliferation in model systems and in humans. Numerous studies have shown that left ventricular hypertrophy (LVH) increases the risk of coronary heart disease, congestive heart failure, stroke or transient ischemic attack; all-cause deaths, and sudden death. The use of angiotensinconverting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) has provi Read More
-
-
-
Dopamine Receptor and Hypertension
Authors: Chunyu Zeng, Gilbert M. Eisner, Robin A. Felder and Pedro A. JoseDopamine plays an important role in the pathogenesis of hypertension by regulating epithelial sodium transport and reactive oxygen and by interacting with vasopressin, renin-angiotensin, and the sympathetic nervous system. Decreased renal dopamine production and / or impaired dopamine receptor function have been reported in hypertension. Disruption of any of the dopamine receptors (D1, D2, D3, D4, and D5) Read More
-
Volumes & issues
Most Read This Month
Article
content/journals/cmccha
Journal
10
5
false
en
